Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

A pilot study of active vitamin D administration and insulin resistance in African American patients undergoing chronic hemodialysis.

Hung AM, Sundell MB, Plotnikova NE, Bian A, Shintani A, Ellis CD, Siew ED, Ikizler TA.

J Ren Nutr. 2013 May;23(3):185-93. doi: 10.1053/j.jrn.2012.06.005. Epub 2012 Sep 7.

PMID:
22959781
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A comparison of novel and commonly-used indices of insulin sensitivity in African American chronic hemodialysis patients.

Hung AM, Sundell MB, Egbert P, Siew ED, Shintani A, Ellis CD, Bian A, Ikizler TA.

Clin J Am Soc Nephrol. 2011 Apr;6(4):767-74. doi: 10.2215/CJN.08070910. Epub 2011 Mar 24.

PMID:
21441124
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Insulin resistance and protein metabolism in chronic hemodialysis patients.

Deger SM, Sundell MB, Siew ED, Egbert P, Ellis CD, Sha F, Ikizler TA, Hung AM.

J Ren Nutr. 2013 May;23(3):e59-66. doi: 10.1053/j.jrn.2012.08.013. Epub 2012 Nov 27.

PMID:
23194840
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with chronic kidney disease: a randomised controlled trial.

Petchey WG, Hickman IJ, Duncan E, Prins JB, Hawley CM, Johnson DW, Barraclough K, Isbel NM.

BMC Nephrol. 2009 Dec 10;10:41. doi: 10.1186/1471-2369-10-41.

PMID:
20003316
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.

Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Dr├╝eke TB, Goodman WG.

N Engl J Med. 2004 Apr 8;350(15):1516-25.

PMID:
15071126
[PubMed - indexed for MEDLINE]
Free Article
6.

Vitamin D deficiency, insulin resistance, serum adipokine, and leptin levels in peritoneal dialysis patients.

Ulutas O, Taskapan H, Taskapan MC, Temel I.

Int Urol Nephrol. 2013 Jun;45(3):879-84. doi: 10.1007/s11255-012-0308-8. Epub 2012 Oct 12.

PMID:
23065434
[PubMed - indexed for MEDLINE]
7.

Economic analysis of cinacalcet in combination with low-dose vitamin D versus flexible-dose vitamin D in treating secondary hyperparathyroidism in hemodialysis patients.

Shireman TI, Almehmi A, Wetmore JB, Lu J, Pregenzer M, Quarles LD.

Am J Kidney Dis. 2010 Dec;56(6):1108-16. doi: 10.1053/j.ajkd.2010.07.012. Epub 2010 Oct 15.

PMID:
20951487
[PubMed - indexed for MEDLINE]
8.

Factors determining insulin resistance in chronic hemodialysis patients.

Hung AM, Ikizler TA.

Contrib Nephrol. 2011;171:127-34. doi: 10.1159/000327177. Epub 2011 May 23. Review.

PMID:
21625101
[PubMed - indexed for MEDLINE]
9.

Cinacalcet lowering of serum fibroblast growth factor-23 concentration may be independent from serum Ca, P, PTH and dose of active vitamin D in peritoneal dialysis patients: a randomized controlled study.

Kim HJ, Kim H, Shin N, Na KY, Kim YL, Kim D, Chang JH, Song YR, Hwang YH, Kim YS, Ahn C, Lee J, Oh KH; Representing the Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect Of iPTH Level (CUPID) Study Group.

BMC Nephrol. 2013 May 25;14:112. doi: 10.1186/1471-2369-14-112.

PMID:
23705925
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Parathyroid hormone is associated with biomarkers of insulin resistance and inflammation, independent of vitamin D status, in obese adolescents.

Alemzadeh R, Kichler J.

Metab Syndr Relat Disord. 2012 Dec;10(6):422-9. doi: 10.1089/met.2012.0056. Epub 2012 Jul 31.

PMID:
22849753
[PubMed - indexed for MEDLINE]
11.

Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.

Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C.

Nephron Clin Pract. 2008;110(1):c58-65. doi: 10.1159/000151534. Epub 2008 Aug 25.

PMID:
18724068
[PubMed - indexed for MEDLINE]
12.

Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study.

Lindberg JS, Culleton B, Wong G, Borah MF, Clark RV, Shapiro WB, Roger SD, Husserl FE, Klassen PS, Guo MD, Albizem MB, Coburn JW.

J Am Soc Nephrol. 2005 Mar;16(3):800-7. Epub 2005 Feb 2.

PMID:
15689407
[PubMed - indexed for MEDLINE]
Free Article
13.

Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in haemodialysis patients.

Floege J, Raggi P, Block GA, Torres PU, Csiky B, Naso A, Nossuli K, Moustafa M, Goodman WG, Lopez N, Downey G, Dehmel B, Chertow GM; ADVANCE Study group.

Nephrol Dial Transplant. 2010 Jun;25(6):1916-23. doi: 10.1093/ndt/gfp762. Epub 2010 Jan 27.

PMID:
20110249
[PubMed - indexed for MEDLINE]
Free Article
14.

A computerized treatment algorithm trial to optimize mineral metabolism in ESRD.

Spiegel DM, McPhatter L, Allison A, Drumheller JC, Lockridge R.

Clin J Am Soc Nephrol. 2012 Apr;7(4):632-9. doi: 10.2215/CJN.08170811. Epub 2012 Feb 2.

PMID:
22300740
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004 through 2006.

St Peter WL, Li Q, Liu J, Persky M, Nieman K, Arko C, Block GA.

Clin J Am Soc Nephrol. 2009 Feb;4(2):354-60. doi: 10.2215/CJN.05241008. Epub 2009 Jan 7.

PMID:
19129318
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D2.

Llach F, Keshav G, Goldblat MV, Lindberg JS, Sadler R, Delmez J, Arruda J, Lau A, Slatopolsky E.

Am J Kidney Dis. 1998 Oct;32(2 Suppl 2):S48-54.

PMID:
9808143
[PubMed - indexed for MEDLINE]
17.

Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism.

Bucharles S, Barberato SH, Stinghen AE, Gruber B, Piekala L, Dambiski AC, Custodio MR, Pecoits-Filho R.

J Ren Nutr. 2012 Mar;22(2):284-91. doi: 10.1053/j.jrn.2011.07.001. Epub 2011 Sep 10.

PMID:
21908203
[PubMed - indexed for MEDLINE]
18.

Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.

Torres PU.

J Ren Nutr. 2006 Jul;16(3):253-8. Review.

PMID:
16825031
[PubMed - indexed for MEDLINE]
19.

Vitamin D deficiency and associated factors in hemodialysis patients.

Jean G, Charra B, Chazot C.

J Ren Nutr. 2008 Sep;18(5):395-9. doi: 10.1053/j.jrn.2008.04.003.

PMID:
18721733
[PubMed - indexed for MEDLINE]
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk